Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Abingdon Health PLC ( (GB:ABDX) ) just unveiled an announcement.
Abingdon Health PLC announced updates to its Long Term Incentive Plan (LTIP), with 16% of the share options awarded in December 2022 now vested based on performance criteria for the financial year ending June 2025. The company has also awarded new LTIPs totaling 3,361,000 shares, set to vest in October 2028, contingent on meeting revenue and EBITDA targets. This move aims to align the interests of directors and senior management with shareholders, potentially impacting company operations and stakeholder interests by incentivizing performance and retention.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider that offers a range of services to an international clientele. The company specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services, catering to sectors such as infectious disease, clinical testing, animal health, and environmental testing. Abingdon Health also provides regulatory services through its subsidiaries, Compliance Solutions (Life Sciences) and IVDeology, supporting the in vitro diagnostic and medical device industries in the USA, EU, and UK.
Average Trading Volume: 125,898
Technical Sentiment Signal: Hold
Current Market Cap: £16.95M
For a thorough assessment of ABDX stock, go to TipRanks’ Stock Analysis page.